Adimab, Inc., a technology leader in the discovery of fully human
antibodies, today announced the initiation of three new independent
research collaborations with Eli Lilly, Genentech, and Human Genome
Sciences. Over the past 18 months Adimab has established collaborations
with several leading Pharmaceutical companies including: Merck, ...
read more